🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Influenza virus is a significant pathogen in pediatric solid organ transpla...
Status
Recruiting
Location
Stanford University
Start Date
2024-09-26
Trial ID
NCT05947071
Lung allograft recipients have a higher burden of influenza disease and gre...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2022-11-08
Trial ID
NCT05215327
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
This study will evaluate the relative vaccine effectiveness of quadrivalent...
Status
Recruiting
Location
Kaiser Permanente Northern California (entire region)
Start Date
2023-08-17
Trial ID
NCT06029933
Primary Objective: To demonstrate the superior relative effectiveness of Q...
Status
Terminated
Location
Investigational Site Number 2469999
Start Date
2019-11-04
Trial ID
NCT04137887
This randomized phase II studies the side effects of high-dose trivalent in...
Status
Completed
Location
University of Alabama
Start Date
2017-10-09
Trial ID
NCT03179761
The objectives of this study were: * To describe the safety of each dosage...
Status
Completed
Location
Investigational Site Number 8400004
Start Date
2018-10-09
Trial ID
NCT03698279
Treatments Being Tested
Primary Objective: To demonstrate that high-dose quadrivalent influenza va...
Status
Completed
Location
Investigational Site Number 0560001
Start Date
2019-10-28
Trial ID
NCT04024228
Treatments Being Tested
The influenza virus is a significant cause of morbidity in adult solid orga...
Status
Active Not Recruiting
Location
Vanderbilt Univeristy Medical Center
Start Date
2021-01-11
Trial ID
NCT04613206
Primary Objective: To demonstrate that QIV-HD induced an immune response (...
Status
Completed
Location
Investigational Site Number 3920005
Start Date
2020-10-21
Trial ID
NCT04498832